Holen Sie sich die Stockscreener-App
8.33
3.03%
-0.26
Vorhandelsmarkt:
8.46
0.13
+1.56%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Novavax Inc Aktie (NVAX) Neueste Nachrichten
Tools to assess Novavax Inc.’s risk profileRecession Risk & Fast Entry Momentum Trade Alerts - newser.com
What analysts say about Novavax Inc NVV1 stockSwing Trading Watchlist & High Profit Growth Stocks - earlytimes.in
Novavax starts late-stage trial of COVID-19 vaccine in United States - Reuters
Novavax Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Will Novavax Inc. continue its uptrendPortfolio Return Summary & Expert Approved Momentum Trade Ideas - newser.com
Statistical indicators supporting Novavax Inc.’s strengthJuly 2025 Analyst Calls & Real-Time Volume Spike Alerts - newser.com
Analyzing Novavax Inc. with risk reward ratio chartsTrade Ideas & Long-Term Investment Growth Plans - newser.com
Is Novavax Inc. stock attractive after correctionWeekly Volume Report & Weekly High Conviction Ideas - newser.com
Automated trading signals detected on Novavax Inc.2025 Volatility Report & Fast Entry High Yield Tips - newser.com
Is Novavax Inc. (NVV1) stock a buy on weakness2025 Pullback Review & Scalable Portfolio Growth Methods - newser.com
Is Novavax Inc. showing signs of accumulationMarket Performance Summary & Reliable Volume Spike Trade Alerts - newser.com
What institutional flow reveals about Novavax Inc.July 2025 Final Week & Fast Gain Stock Tips - newser.com
Novavax Inc Completes EU Marketing Authorization Transfer for Nuvaxovid - TradingView
Novavax Inc. Stock Slides 3.5%, Underperforms Peers - 富途牛牛
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance
Novavax, Inc. Experiences Evaluation Revision Amid Mixed Market Performance Indicators - Markets Mojo
Novavax (NVAX) Transfers EU Vaccine Rights to Sanofi for $25M - GuruFocus
Shah Capital Management Has $72.52 Million Stock Position in Novavax, Inc. $NVAX - MarketBeat
Novavax hands over Nuvaxovid marketing rights to Sanofi in the EU - Seeking Alpha
Novavax Continues to Deliver on Sanofi Partnership, Completion Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment - MarketScreener
Novavax Completes Transfer of Marketing Authorization for COVID-19 Vaccine in EU to Sanofi - MarketScreener
Sanofi (SNY) Gains Full EU Control of Nuvaxovid from Novavax - GuruFocus
Novavax receives $25 million milestone payment from Sanofi partnership - Investing.com
Novavax Transfers EU Vaccine Rights to Sanofi - TipRanks
$25M Milestone: Novavax Transfers Nuvaxovid EU Authorization to Sanofi; Eligible for Up to $350M - Stock Titan
Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance
Novavax Inc Stock Analysis and ForecastMerger & Acquisition Updates & Free Fastest Return On Investment - earlytimes.in
Is Novavax Inc. stock attractive for retirement portfoliosQuarterly Profit Review & Short-Term High Return Strategies - newser.com
Will Novavax Inc. (NVV1) stock benefit from sector leadershipJuly 2025 Short Interest & Weekly Top Performers Watchlists - newser.com
Smart tools for monitoring Novavax Inc.’s price actionMarket Growth Summary & Breakout Confirmation Alerts - newser.com
Will Novavax Inc. outperform the marketStop Loss & Verified Momentum Stock Watchlist - newser.com
Can Novavax Inc. rally from current levelsTrade Volume Report & AI Powered Buy/Sell Recommendations - newser.com
Using Bollinger Bands to evaluate Novavax Inc.Analyst Downgrade & High Yield Stock Recommendations - newser.com
Will Novavax Inc. stock benefit from AI adoptionQuarterly Growth Report & High Accuracy Investment Entry Signals - newser.com
Analyzing recovery setups for Novavax Inc. investorsWeekly Trade Summary & Weekly High Return Forecasts - newser.com
Novavax (NVAX) Is Up 10.6% After Sanofi Expands Matrix-M Licensing AgreementHas the Bull Case Changed? - Yahoo Finance
Novavax Inc. (NVAX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
A Fresh Look at Novavax (NVAX) Valuation After Recent Share Price Rebound - Yahoo Finance
Novavax allows Sanofi to use Matrix-M adjuvant for pandemic flu candidate - MSN
Novavax, Inc. (NASDAQ:NVAX) Held Back By Insufficient Growth Even After Shares Climb 27% - 富途牛牛
Noteworthy Wednesday Option Activity: ONON, NVAX, COMM - Nasdaq
Novavax’s Vaccine Milestone and Market Movement - StocksToTrade
Novavax Announces Progress on Sanofi Agreement - Sahm
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):